Hepatocellular Carcinoma Screening Is Associated With Increased Survival of Patients With Cirrhosis.

ABSTRACT:

Background & aims

Hepatocellular carcinoma (HCC) screening of patients with cirrhosis is recommended by professional societies to increase detection of early stage tumors and survival, but is underused in clinical practice.

Methods

We conducted a retrospective cohort study of 13,714 patients diagnosed with HCC from 2003 through 2013 included in the Surveillance, Epidemiology, and End Results Program-Medicare database. We characterized receipt of HCC screening in the 3 years before HCC diagnosis using mutually exclusive categories (consistent vs inconsistent vs no screening) and the proportion of time covered with screening. Correlates for screening receipt were assessed using a multivariable 2-part regression model. We examined the association between screening receipt and e

SUBMITTER: Choi DT 

PROVIDER: S-EPMC6431264 | biostudies-literature | 2019 Apr

REPOSITORIES: biostudies-literature